Neurizon Therapeutics Ltd

NUZ

Company Profile

  • Business description

    Neurizon Therapeutics Ltd is a clinical-stage biotech company that develops drug discovery intellectual property for the treatment of different types of neurodegenerative diseases. Its product pipeline is NUZ-001 (S-Monepantel).

  • Contact

    96-100 Albert Road
    Level 4
    South Melbourne
    MelbourneVIC3205
    AUS

    T: +61 396927222

    https://www.neurizon.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2025

    Employees

    52

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,631.5042.700.50%
CAC 407,826.791.34-0.02%
DAX 4024,226.49198.840.83%
Dow JONES (US)42,343.65740.581.78%
FTSE 1008,778.0560.080.69%
HKSE23,381.9999.660.43%
NASDAQ19,199.16461.962.47%
Nikkei 22537,724.11192.580.51%
NZX 50 Index12,582.3335.110.28%
S&P 5005,921.54118.722.05%
S&P/ASX 2008,407.6046.600.56%
SSE Composite Index3,340.696.15-0.18%

Market Movers